Perennial Allergic Rhinitis (PAR)
1 competing product in clinical development for Perennial Allergic Rhinitis (PAR).
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| LY3650150 + Placebo + Standard therapy for INCS | Eli Lilly | Phase 3 | Recruiting | 77 |